Implementing Thrombosis Guidelines in Cancer Patients: A Review

Dominique Farge-Bancel, Henri Bounameaux, Benjamin Brenner, Harry R. Büller, Ajay Kakkar, Ingrid Pabinger, Michael Streiff, and Philippe Debourdeau

Abstract

Venous thromboembolism is a frequent and serious complication in patients with cancer. It is an independent prognostic factor of death in cancer patients and the second leading cause of death, but physicians often underestimate its importance, as well as the need for adequate prevention and treatment. Management of venous thromboembolism in patients with cancer requires the coordinated efforts of a wide range of clinicians, highlighting the importance of a multidisciplinary approach. However, a lack of consensus among various national and international clinical practice guidelines has contributed to knowledge and practice gaps among practitioners, and inconsistent approaches to venous thrombo-embolism. The 2013 international guidelines for thrombosis in cancer have sought to address these gaps by critically re-evaluating the evidence coming from clinical trials and synthesizing a number of guidelines documents. An individualized approach to prophylaxis is recommended for all patients.

Rambam Maimonides Med J 2014;5(4):e0041